INR 78.05
(-4.33%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 73.47 Million INR | -35.19% |
2022 | 113.38 Million INR | 117.36% |
2021 | 52.16 Million INR | -10.48% |
2020 | 58.26 Million INR | 123.56% |
2019 | -247.29 Million INR | -31.05% |
2018 | -188.7 Million INR | -12.75% |
2017 | -167.36 Million INR | 12.31% |
2016 | -190.86 Million INR | -36.07% |
2015 | -140.26 Million INR | -327.07% |
2014 | 61.77 Million INR | 340.11% |
2013 | 14.03 Million INR | -64.58% |
2012 | 39.62 Million INR | 115.27% |
2011 | 18.4 Million INR | -45.02% |
2010 | 33.48 Million INR | 34.93% |
2009 | 24.81 Million INR | 132.44% |
2008 | 10.67 Million INR | -10.92% |
2007 | 11.98 Million INR | 23.75% |
2006 | 9.68 Million INR | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -7.23 Million INR | -149.72% |
2023 Q2 | 24.83 Million INR | -60.89% |
2023 Q4 | 14.55 Million INR | 149.46% |
2023 FY | 73.47 Million INR | -35.19% |
2023 Q3 | -29.42 Million INR | -218.46% |
2023 Q1 | 63.51 Million INR | 18.23% |
2022 FY | 113.38 Million INR | 117.36% |
2022 Q1 | 13.62 Million INR | 234.2% |
2022 Q2 | 16.08 Million INR | 18.12% |
2022 Q3 | 29.95 Million INR | 86.16% |
2022 Q4 | 53.71 Million INR | 79.35% |
2021 Q4 | -10.15 Million INR | -159.61% |
2021 Q1 | 20.87 Million INR | -20.83% |
2021 FY | 52.16 Million INR | -10.48% |
2021 Q2 | 23.76 Million INR | 13.86% |
2021 Q3 | 17.02 Million INR | -28.34% |
2020 Q1 | 18.11 Million INR | 538.33% |
2020 FY | 58.26 Million INR | 123.56% |
2020 Q4 | 26.36 Million INR | 192.76% |
2020 Q3 | 9 Million INR | 88.09% |
2020 Q2 | 4.78 Million INR | -73.58% |
2019 Q1 | -21.27 Million INR | 84.89% |
2019 FY | -247.29 Million INR | -31.05% |
2019 Q4 | -4.13 Million INR | 98.15% |
2019 Q3 | -223.29 Million INR | -3953.2% |
2019 Q2 | -5.5 Million INR | 74.11% |
2018 Q2 | -12.23 Million INR | 48.97% |
2018 FY | -188.7 Million INR | -12.75% |
2018 Q4 | -140.8 Million INR | -22309.46% |
2018 Q3 | 634 Thousand INR | 105.18% |
2018 Q1 | -23.96 Million INR | 0.0% |
2017 FY | -167.36 Million INR | 12.31% |
2016 FY | -190.86 Million INR | -36.07% |
2015 FY | -140.26 Million INR | -327.07% |
2014 FY | 61.77 Million INR | 340.11% |
2013 FY | 14.03 Million INR | -64.58% |
2012 Q1 | 10.61 Million INR | 0.0% |
2012 Q2 | 36.25 Million INR | 241.62% |
2012 Q3 | 14.08 Million INR | -61.15% |
2012 Q4 | -5.75 Million INR | -140.85% |
2012 FY | 39.62 Million INR | 115.27% |
2011 FY | 18.4 Million INR | -45.02% |
2010 FY | 33.48 Million INR | 34.93% |
2009 FY | 24.81 Million INR | 132.44% |
2008 FY | 10.67 Million INR | -10.92% |
2007 FY | 11.98 Million INR | 23.75% |
2006 FY | 9.68 Million INR | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Sigachi Industries Limited | 571.8 Million INR | 87.15% |
Ind-Swift Limited | 142.31 Million INR | 48.368% |
Bajaj HealthCare Limited | -837.93 Million INR | 108.769% |
Sakar Healthcare Limited | 116.7 Million INR | 37.041% |
Aurobindo Pharma Limited | 31.72 Billion INR | 99.768% |
Innova Captab Limited | 943.45 Million INR | 92.212% |
Divi's Laboratories Limited | 16 Billion INR | 99.541% |
AstraZeneca Pharma India Limited | 1.61 Billion INR | 95.45% |
Morepen Laboratories Limited | 961.59 Million INR | 92.359% |
Mankind Pharma Limited | 19.12 Billion INR | 99.616% |
Sequent Scientific Limited | -358.69 Million INR | 120.485% |
Wanbury Limited | 559.56 Million INR | 86.869% |
Laurus Labs Limited | 1.6 Billion INR | 95.423% |
Nectar Lifesciences Limited | 49.95 Million INR | -47.105% |
Glenmark Life Sciences Limited | 4.7 Billion INR | 98.44% |
Alembic Limited | 2.68 Billion INR | 97.265% |
Hikal Limited | 696 Million INR | 89.443% |
Alembic Pharmaceuticals Limited | 6.15 Billion INR | 98.807% |
Neuland Laboratories Limited | 3 Billion INR | 97.551% |
J. B. Chemicals & Pharmaceuticals Limited | 5.52 Billion INR | 98.67% |
Glenmark Pharmaceuticals Limited | -15.01 Billion INR | 100.489% |
IOL Chemicals and Pharmaceuticals Limited | 1.34 Billion INR | 94.534% |
Themis Medicare Limited | 435.23 Million INR | 83.118% |
RPG Life Sciences Limited | 876.6 Million INR | 91.618% |
Zydus Lifesciences Limited | 38.59 Billion INR | 99.81% |
Lupin Limited | 19.14 Billion INR | 99.616% |
Amrutanjan Health Care Limited | 449.72 Million INR | 83.661% |
Wockhardt Limited | -4.63 Billion INR | 101.587% |
Vaishali Pharma Limited | 7.18 Million INR | -922.103% |
Aarti Pharmalabs Limited | 2.16 Billion INR | 96.612% |
Jagsonpal Pharmaceuticals Limited | 224.63 Million INR | 67.289% |
Jubilant Pharmova Limited | 771 Million INR | 90.47% |
FDC Limited | 3.05 Billion INR | 97.593% |
Dr. Reddy's Laboratories Limited | 55.68 Billion INR | 99.868% |
Kilitch Drugs (India) Limited | 146.01 Million INR | 49.677% |
Eris Lifesciences Limited | 3.91 Billion INR | 98.125% |
Venus Remedies Limited | 284.9 Million INR | 74.21% |
ZIM Laboratories Limited | 172.46 Million INR | 57.395% |
Bliss GVS Pharma Limited | 754.54 Million INR | 90.262% |
Par Drugs and Chemicals Limited | 145.01 Million INR | 49.328% |
Caplin Point Laboratories Limited | 4.57 Billion INR | 98.392% |
Shilpa Medicare Limited | 318.74 Million INR | 76.947% |
Albert David Limited | 754.2 Million INR | 90.257% |
Ajanta Pharma Limited | 8.16 Billion INR | 99.1% |
Hester Biosciences Limited | 188.89 Million INR | 61.1% |
Suven Pharmaceuticals Limited | 3 Billion INR | 97.553% |
Solara Active Pharma Sciences Limited | -5.67 Billion INR | 101.295% |
Gufic Biosciences Limited | 861.35 Million INR | 91.469% |
Windlas Biotech Limited | 581.87 Million INR | 87.372% |
Procter & Gamble Health Limited | 2 Billion INR | 96.344% |
Aarey Drugs & Pharmaceuticals Limited | 46.83 Million INR | -56.883% |
Mangalam Drugs & Organics Limited | -90.71 Million INR | 180.998% |
Granules India Limited | 4.05 Billion INR | 98.187% |
Aarti Drugs Limited | 1.71 Billion INR | 95.713% |
Bal Pharma Limited | 73.92 Million INR | 0.599% |
Alkem Laboratories Limited | 17.95 Billion INR | 99.591% |
Sun Pharmaceutical Industries Limited | 95.76 Billion INR | 99.923% |
Lincoln Pharmaceuticals Limited | 933.04 Million INR | 92.125% |
Medicamen Biotech Limited | 109.31 Million INR | 32.779% |
Unichem Laboratories Limited | -704.74 Million INR | 110.426% |
Biofil Chemicals and Pharmaceuticals Limited | 7.09 Million INR | -936.083% |
Valiant Laboratories Limited | 3.19 Million INR | -2199.093% |
Orchid Pharma Limited | 921.66 Million INR | 92.028% |
Medico Remedies Limited | 82.9 Million INR | 11.374% |
Ind-Swift Laboratories Limited | 4.2 Billion INR | 98.254% |
Ipca Laboratories Limited | 5.47 Billion INR | 98.658% |
Brooks Laboratories Limited | -195.91 Million INR | 137.505% |
Syncom Formulations (India) Limited | 253.14 Million INR | 70.973% |
Piramal Enterprises Limited | -16.83 Billion INR | 100.436% |
Torrent Pharmaceuticals Limited | 16.56 Billion INR | 99.556% |
NATCO Pharma Limited | 13.88 Billion INR | 99.471% |
Suven Life Sciences Limited | -1.05 Billion INR | 106.993% |
Krebs Biochemicals & Industries Limited | -197.28 Million INR | 137.245% |
Strides Pharma Science Limited | -706.14 Million INR | 110.406% |
Indoco Remedies Limited | 984.6 Million INR | 92.537% |
Alpa Laboratories Limited | 167.76 Million INR | 56.201% |
Lasa Supergenerics Limited | -217.3 Million INR | 133.814% |
Sun Pharma Advanced Research Company Limited | -3.87 Billion INR | 101.898% |